Patent details

EP1402075 Title: DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES

Basic Information

Publication number:
EP1402075
PCT Application Number:
PCT/US/2002/016308
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027393586
PCT Publication Number:
WO/2002/095075
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES
French Title of Invention:
MISE AU POINT DE MUTATIONS UTILES POUR L'ATTENUATION DES VIRUS DE LA DENGUE ET DES VIRUS DE LA DENGUE CHIMERIQUES
German Title of Invention:
ENTWICKLUNG VON ZUR ATTENUIERUNG VON DENGUE-VIREN GEEIGNETEN MUTATIONEN UND CHIMÄRE DENGUE-VIREN
SPC Number:

Dates

Filing date:
22/05/2002
Grant date:
14/11/2012
EP Publication Date:
14/11/2012
PCT Publication Date:
28/11/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/03/2004
EP B1 Publication Date:
14/11/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/05/2013
Expiration date:
22/05/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/05/2002
 
 

Name:
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as
Address:
National Institutes of Health, Office of Technology Transfe, Rockville, MD 20852-3804, United States (US)

Inventor

1

Name:
BLANEY Joseph, E., Jr.
Address:
United States (US)

2

Name:
WHITEHEAD Stephen, S.
Address:
United States (US)

3

Name:
HANLEY Kathryn, A.
Address:
United States (US)

4

Name:
MURPHY Brian, R.
Address:
United States (US)

Priority

Priority Number:
293049 P
Priority Date:
22/05/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
C12Q 1/70;
Filing date Document type Number of pages